IMPACT OF SRC VARIANTS ON ALZHEIMER’S DISEASE
Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE
Presentation
Date TBA
Event Information
Poster Board
PS05-09AM-192
Poster
View posterAbstract
Alzheimer’s disease (AD) is a complex multifactorial pathology, and understanding the genetics of common forms may improve knowledge of its underlying mechanisms. Genome-wide association studies have identified several genetic determinants, including FERMT2, which encodes KINDLIN2, a regulator of APP metabolism and Aβ production. We previously showed that KINDLIN2 directly interacts with APP and modulates synaptic plasticity. Here, we identify SRC as a novel modulator of APP metabolism through its influence on the KINDLIN2/APP complex. Exome sequencing data from 32,558 individuals were analyzed to assess the burden of predicted damaging rare variants in SRC associated with AD risk. Functional consequences of these variants were evaluated by analyzing (i) SRC/KINDLIN2 interactions using NMR, GST pull-down and Proximity Ligation Assay (PLA), and (ii) APP metabolism and Aβ production in a HEK293-APP model. The synaptic localization of the interaction was examined in primary neuronal cultures using PLA combined with synaptic markers, while neuronal activity was assessed using Microelectrode Array (MEA). In parallel, iPSCs carrying the SRC V177L variant were edited by CRISPR/Cas9 to evaluate its impact in human induced neurons. We demonstrate the existence of a SRC/KINDLIN2/APP complex in which APP stabilizes the SRC–KINDLIN2 interaction. Rare damaging SRC variants were associated with increased AD risk. The SRC V177L variant was associated with accumulation of APP-derived byproducts, including Aβ peptides, and showed reduced binding to KINDLIN2 compared with wild-type SRC. Overall, our findings identify SRC, KINDLIN2 and APP as genetic determinants of AD forming a synaptic complex whose disruption may promote synaptic dysfunction.
Recommended posters
IDENTIFICATION OF A FUNCTIONAL VARIANT IN THE ALZHEIMER’S DISEASE GENETIC RISK FACTOR PTK2B
Nina Lannette-Weimann, Ana-Raquel Melo de Farias, Morgane Lemaire, Charlotte Henocq, Audrey Coulon, Pauline Walle, Limoge Floriane, Leo Morita Myakoshi, Angelika Dannert, Judit Gonzalez Gallego, Chloé Najdek, Marcos Costa, Philippe Amouyel, Dominik Paquet, Julien Chapuis, Jean-Charles Lambert, Julie Dumont
PROTEIN-TRUNCATING VARIANTS OF SORL1 INITIATE SPECIFIC PROTEOMIC AND TRANSCRIPTOMIC ALTERATIONS IN ALZHEIMER’S DISEASE
Balázs Pósfai, Sára Vida, Krisztina Tóth, Henne Holstege, Olav M. Andersen, Ádám Dénes
IDENTIFYING A NEURONAL ROLE FOR THE GENETIC RISK FACTOR PLCG2 IN ALZHEIMER’S DISEASE
Audrey Coulon, Florian Rabiller, Mari Takalo, Avishek Roy, Alexandre Pelletier, Henna Martiskainen, Dolores Siedlecki-Wullich, Nina Lannette-Weimann, Nad'a Majernikova, Anaël Ehrardt, Floriane Limoge, Morgane Lemaire, Florie Demiautte, Karine Guyot, Julia TCW, Manon Muntaner, Benjamin Grenier-Boley, Delphine Eberlé, Séverine Deforges, Joel Haas, Devrim Kilinc, Christophe Mulle, Julien Chapuis, Mikko Hiltunen, Jean-Charles Lambert, Julie Dumont
FUNCTIONAL EVALUATION OF GENETIC VARIANTS RELATED TO POLYGENIC RISK FOR ALZHEIMER’S DISEASE USING A MASSIVELY PARALLEL REPORTER ASSAY
Danna Perlaza Meneses, Laia Lidón, Alba Cervantes-González, Xuanyang Bai, María Dolores Capilla-López, Esther Álvarez-Sánchez, Natalia Valle-Tamayo, Aleyda Benitez Amaro, Borja Moya-Llamas, Érika Sánchez-Aced, Joaquim Aumatell Escabias, Laia Muñoz, Laura Cervera-Carles, Sònia Sirisi-Dolcet, Oriol Dols-Icardo, Alberto Lleó, Olivia Belbin
IMPACT OF SORL1 DEFICIENCY ON MITOCHONDRIAL DYNAMICS, CALCIUM HANDLING AND OXIDATIVE STRESS IN ALZHEIMER’S DISEASE
Guiomar Rodríguez, Raquel Míguez-Rodríguez, María Mora Velasco, Andrea Izquierdo Vitalla, Marina Bosch-Juan, Macarena De la Cueva de Vicente, Paula Hernández Ruiz de Azcárate, Sara del Rey Mateos, Alberto Villarejo Galende, Marta González Sánchez, Víctor Antonio Blanco-Palmero, Fernando Bartolomé Robledo
EXPLORING THE ROLE OF ABI3 AND THE CONSEQUENCES OF THE ALZHEIMER’S DISEASE RISK VARIANT S209F ON MICROGLIAL FUNCTION
Shania Ibarra, Emma Murphy, Emma Mead, Katerina Gospodinova